光敏剂
光动力疗法
材料科学
生物物理学
癌细胞
激光器
纳米载体
DNA
癌症研究
纳米技术
纳米颗粒
光化学
癌症
化学
生物化学
生物
光学
物理
有机化学
遗传学
作者
Zhao Hai,Linghui Li,Feng Li,Chunxia Liu,Mengxue Huang,Jiao Li,Feng Gao,Xinhua Ruan,Dayong Yang
标识
DOI:10.1002/adma.202109920
摘要
Photodynamic therapy (PDT) is a therapeutic strategy that is dependent on external light irradiation that faces a major challenge in cancer treatment due to the poor tissue-penetration depths of light irradiation. Herein, a DNA nanocomplex that integrates persistent-luminescence nanoparticles (PLNPs) is developed, which realizes tumor-site glutathione-activated PDT for breast cancer without exogenous laser excitation. The scaffold of the nanocomplex is AS1411-aptamer-encoded ultralong single-stranded DNA chain with two functions: i) providing sufficient intercalation sites for the photosensitizer, and ii) recognizing nucleolin that specifically overexpresses on the surface of cancer cells. The PLNPs in the nanocomplex are energy-charged to act as a self-illuminant and coated with a shell of MnO2 for blocking energy degradation. In response to the overexpressed glutathione in cancer cells, the MnO2 shell decomposes to provide Mn2+ to catalytically produce O2 , which is essential to PDT. Meanwhile, PLNPs are released and act as a self-illuminant to activate the photosensitizer to convert O2 into cytotoxic 1 O2 . Significant tumor inhibition effects are demonstrated in breast tumor xenograft models without exogenous laser excitation. It is envisioned that a laser-excitation-free PDT strategy enabled by the PLNP-DNA nanocomplex promotes the development of PDT and provides a new local therapeutic approach.
科研通智能强力驱动
Strongly Powered by AbleSci AI